The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor, and inhibitor of regulatory T cells induces effective immune responce against Hepatitis C virus

作者: O. V. Masalova , E. I. Lesnova , L. N. Shingarova , V. L. Tunitskaya , T. I. Ulanova

DOI: 10.1134/S0026893312030077

关键词:

摘要: Hepatitis C is related to the most important socially significant human infectious diseases; however, vaccine against this virus up now has notbeen created. One of possible components nonstructural protein NS3 hepatitis (HCV), which synthesized in infected cells and displays protease, NTPase, helicase enzymatic activities. The connection between effectiveness ofT cellular response epitopes spontaneous resolution acute was shown. purpose work compare immune mice inoculation nucleotide amino acid sequences HCV their combination, evaluate adjuvant activity DNA encoding granulocyte macrophage colony-stimulating factor (GM-CSF) influence regulatory T on response. maximum anti-HCV antibody level serum (to 1:640000) induced recombinant rNS3 introduced with aluminum hydroxide. intensive observed after simultaneous administration DNAs full-size GM-CSF. A high lymphocyte proliferation, accumulation IFN-gamma-secreting IFN-gamma, IL-2 release stimulators--NS3 antigens different composition were group mice. It been established that suppression vitro leads statistically increase secretion IFN-gamma. Thus, application along GM-CSF promising approach for development vaccine. expediency inclusion cell inhibitors will be clear special studies.

参考文章(30)
Julian Schulze zur Wiesch, Georg M. Lauer, Cheryl L. Day, Arthur Y. Kim, Kei Ouchi, Jared E. Duncan, Alysse G. Wurcel, Joerg Timm, Andrea M. Jones, Bianca Mothe, Todd M. Allen, Barbara McGovern, Lia Lewis-Ximenez, John Sidney, Alessandro Sette, Raymond T. Chung, Bruce D. Walker, Broad Repertoire of the CD4+ Th Cell Response in Spontaneously Controlled Hepatitis C Virus Infection Includes Dominant and Highly Promiscuous Epitopes Journal of Immunology. ,vol. 175, pp. 3603- 3613 ,(2005) , 10.4049/JIMMUNOL.175.6.3603
Margaret Chen, Matti Sällberg, Anders Sönnerborg, Ling Jin, Ashley Birkett, Darrell Peterson, Ola Weiland, David R. Milich, Human and murine antibody recognition is focused on the ATPase/Helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein Hepatology. ,vol. 28, pp. 219- 224 ,(1998) , 10.1002/HEP.510280128
Mazen Albeldawi, Ernesto Ruiz-Rodriguez, William D. Carey, Hepatitis C virus: prevention, screening, and interpretation of assays. Cleveland Clinic Journal of Medicine. ,vol. 77, pp. 616- 626 ,(2010) , 10.3949/CCJM.77A.09162
J. Encke, W. Radunz, C. Eisenbach, J. Geib, S. Gehrke, E. Pfaff, W. Stremmel, Development of a heterologous, multigenotype vaccine against hepatitis C virus infection European Journal of Clinical Investigation. ,vol. 37, pp. 396- 406 ,(2007) , 10.1111/J.1365-2362.2007.01802.X
Masanori Matsui, Osamu Moriya, Maria Laura Belladonna, Sadahiro Kamiya, François A. Lemonnier, Takayuki Yoshimoto, Toshitaka Akatsuka, Adjuvant Activities of Novel Cytokines, Interleukin-23 (IL-23) and IL-27, for Induction of Hepatitis C Virus-Specific Cytotoxic T Lymphocytes in HLA-A*0201 Transgenic Mice Journal of Virology. ,vol. 78, pp. 9093- 9104 ,(2004) , 10.1128/JVI.78.17.9093-9104.2004
Mark A.A. Claassen, Robert J. de Knegt, Hugo W. Tilanus, Harry L.A. Janssen, André Boonstra, Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis Journal of Hepatology. ,vol. 52, pp. 315- 321 ,(2010) , 10.1016/J.JHEP.2009.12.013
Michael Houghton, Sergio Abrignani, Prospects for a vaccine against the hepatitis C virus Nature. ,vol. 436, pp. 961- 966 ,(2005) , 10.1038/NATURE04081
L. Alvarez-Lajonchere, N. H. Shoukry, B. Grá, Y. Amador-Cañizares, F. Helle, N. Bédard, I. Guerra, C. Drouin, J. Dubuisson, E. E. González-Horta, G. Martínez, J. Marante, Z. Cinza, M. Castellanos, S. Dueñas-Carrera, Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial Journal of Viral Hepatitis. ,vol. 16, pp. 156- 167 ,(2009) , 10.1111/J.1365-2893.2008.01058.X
M. Ghorbani, T. Nass, A. Azizi, C. Soare, S. Aucoin, A. Giulivi, D.E. Anderson, F. Diaz-Mitoma, Comparison of antibody- and cell-mediated immune responses after intramuscular hepatitis C immunizations of BALB/c mice. Viral Immunology. ,vol. 18, pp. 637- 648 ,(2005) , 10.1089/VIM.2005.18.637